Stock Report

All about this stock under one free report Last Updated: 27-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

EP Biocomposites Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 543595

₹103.20

up-down-arrow ₹7.15 (7.44%)

As on 25-Aug-2026IST

Market cap

info icon

₹17 Cr

Revenue (TTM)

info icon

₹12 Cr

P/E Ratio

info icon

11.9

P/B Ratio

info icon

1.6

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- 4.96 14.21 84.08
EBIT -- -- 27.22 7.47 107.62
Net Profit -- -- -10.34 8.39 100.90
EPS -- -- -10.34 -3.74 48.81
Book Value -- -- 10.78 54.84 141.94
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsMar-25Mar-24Mar-23
EBIT-Margin info 12.5513.9913.8811.4512.31
Net Margin info 8.739.678.519.797.90
Return on equity info 11.3654.9010.2312.7911.07
Return on Capital info 14.2461.5014.2415.2813.21
Return on Assets info 6.8614.816.518.585.49
Debt to Equity (x) info ----0.280.190.15

Profitability

View Detailed Peer Comparison

ROCE

14.24

Lower than Peers by 2.04

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EP Biocomposites
14.24
15.28
13.21
41.82
222.95
Peer Median
16.28
15.30
19.64
14.40
--
ROE

10.23

Lower than Peers by 8.64

Profit after tax / Average Net worth * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EP Biocomposites
10.23
12.79
11.07
67.88
172.53
Peer Median
18.86
18.29
17.65
12.90
--
ROA

6.51

Lower than Peers by 3.37

Profit after tax / Average Total assets * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EP Biocomposites
6.51
8.58
5.49
15.27
38.18
Peer Median
9.88
7.57
8.45
7.32
--
EBIT Margin

13.88

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EP Biocomposites
13.88
11.45
12.31
16.66
15.64
Peer Median
--
55.84
21.34
19.21
--
Net Margin

8.51

Lower than Peers by 3.89

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EP Biocomposites
8.51
9.79
7.90
10.02
12.13
Peer Median
12.40
8.70
9.13
8.58
--
Cash Profit Margin

9.52

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EP Biocomposites
9.52
10.93
9.48
10.86
12.15
Peer Median
--
0.00
0.00
0.00
--

Growth

View Detailed Peer Comparison

Revenue Growth

4.96

--

Year on year growth in net sales

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EP Biocomposites
4.96
60.42
-11.52
173.39
418.92
Peer Median
--
--
40.96
78.80
--
EBIT Growth

27.22

--

Year on year growth in operating profit (EBIT)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EP Biocomposites
27.22
49.24
-34.62
191.15
967.36
Peer Median
--
--
37.35
300.95
--
Net Profit Growth

-10.34

--

Year on year growth in profit after tax

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EP Biocomposites
-10.34
99.57
-28.82
126.09
1,036.51
Peer Median
--
--
24.24
396.58
--
EPS Growth

-10.34

--

Year on year growth in earnings per share

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EP Biocomposites
-10.34
99.57
-50.16
-28.00
1,036.51
Peer Median
--
--
33.33
342.84
--
Book Value Growth

10.78

--

Year on year growth in book value per share

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EP Biocomposites
10.78
13.66
321.06
417.05
1,256.14
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.28

Higher than Peers by 0.11

Total debt / Net worth

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EP Biocomposites
0.28
0.19
0.15
2.06
--
Peer Median
0.17
0.62
0.24
0.36
--
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EP Biocomposites
--
0.07
--
0.94
--
Peer Median
--
--
--
--
--
Current Ratio

3.95

Higher than Peers by 1.34

Current Assets / Current Liabilities and Provisions

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EP Biocomposites
3.95
2.84
4.45
1.73
1.39
Peer Median
2.60
1.69
1.86
1.71
--
Quick Ratio

3.55

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EP Biocomposites
3.55
2.60
3.96
1.49
0.91
Peer Median
--
4.08
5.71
4.46
--
Interest Coverage

4.95

Lower than Peers by 4.15

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EP Biocomposites
4.95
42.11
4.54
7.06
387.83
Peer Median
9.11
4.32
6.06
7.39
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

90.43

--

Debtors outstanding / Net Sales * 100

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EP Biocomposites
90.43
78.65
82.20
88.05
21.95
Peer Median
--
28.82
22.19
9,644.00
--
Asset Turnover

0.76

--

Sales / Average Total Assets

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EP Biocomposites
0.76
0.85
0.68
1.52
3.14
Peer Median
--
9.24
2.06
1.12
--
Receivable days

301.79

--

Average Debtors / Sales * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EP Biocomposites
301.79
237.06
331.63
175.34
58.75
Peer Median
--
--
--
--
--
Inventory Days

37.18

--

Average Inventory / Sales * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EP Biocomposites
37.18
32.72
56.27
36.97
34.74
Peer Median
--
--
--
--
--
Payable days

118.43

--

Average Creditors / Cost of goods sold * 365

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EP Biocomposites
118.43
100.33
150.42
104.49
142.02
Peer Median
--
--
--
--
--
Cash Conversion Cycle

220.55

--

Receivable Days + Inventory Days - Payable Days

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EP Biocomposites
220.55
169.45
237.48
107.82
-48.53
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

20.13

Lower than Peers by 3.58

Current share price divided by earning per share in the last twelve months

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EP Biocomposites
20.13
20.06
58.81
--
--
Peer Median
23.71
43.12
39.73
20.53
--
Price / Book Value

1.96

Lower than Peers by 1.48

Current share price divided by book value per share in the latest financial year

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EP Biocomposites
1.96
2.41
4.03
--
--
Peer Median
3.44
6.22
5.37
3.03
--
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EP Biocomposites
--
--
--
--
--
Peer Median
--
--
--
--
--
EV/EBITDA

11.71

Lower than Peers by 21.63

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EP Biocomposites
11.71
13.80
28.83
3.60
-0.21
Peer Median
33.35
45.90
17.05
10.81
--
Market Cap

21

Lower than Peers by 362

Current Share price multiplied by latest total number of shares outstanding

Company Name
Mar-25
Mar-24
Mar-23
Mar-22
Mar-21
EP Biocomposites
21
23
34
--
--
Peer Median
383
590
298
218
--
loading...
loading...
loading...